Ceftriaxone: increasing the half-life and activity of third generation cephalosporins.
D001424:Bacterial Infections / Q000188:drug therapy; D002439:Cefotaxime / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D002443:Ceftriaxone; D002511:Cephalosporins / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D006207:Half-Life; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007700:Kinetics
D002511:Cephalosporins; D002443:Ceftriaxone; D002439:Cefotaxime